FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection
This article was originally published in The Tan Sheet
Executive Summary
Ibuprofen 400 mg may interfere with the cardioprotective effect of uncoated low-dose (81 mg) aspirin when they are concomitantly dosed, FDA said in a Sept. 8 science paper
You may also be interested in...
Naproxen Fares Better Than Ibuprofen In Cardiovascular-Risk Data
Traditional non-selective NSAIDs, with the exception of naproxen, carry similar cardiovascular risk to COX-2 inhibitors, according to results of a study released by the Agency for Healthcare Research & Quality (AHRQ) Sept. 25
Ibuprofen, Preventive Aspirin Therapy May Have “Deleterious” Effect – Study
Ibuprofen combined with aspirin therapy for secondary prevention of cardiovascular disease "may be deleterious," researchers say in the Feb. 15 The Lancet
Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.